kotak-logo
Products
Platform
Research
Market
Learn
Partner
Support
IPO

N

Nephrocare Health Services Share Price

575.25
-6.70 (-1.15%)
NEPHROPLUS • 12 Feb, 2026 | 03:29 PM
Buywith MTF at 1x leverage
The current prices are delayed, login or Open Demat Account for live prices.

Nephrocare Health Services Stock Performance

1W Return10.64
1Y Return0.00
Today's Low568.1
Prev. Close581.95
Mkt Cap (Cr.)5,839.33
1M Return18.46
3Y Return0.00
52-Week High603.8
Open582.00
PE Ratio0.00
6M Return0.00
Today's High589
52-Week Low446
Face Value2

Nephrocare Health Services Company background

Founded in: 2009
Managing director: Vikram Vuppala
Nephrocare Health Services Limited was incorporated as Nephrocare Health Services Private Limited, a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009. Company was converted into a public limited company and the name was changed to Nephrocare Health Services Limited with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.Company offer comprehensive dialysis care through a network of clinics from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. The Company began journey in 2010 with the launch of its first dialysis clinic in Hyderabad. It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012 acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd. in 2018 launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc in 2020.The Company acquired 6 clinics dialysis network with 35000 annual tretaments in 2023 . Further, it has acquired a chain of 7 clinics dialysis network such as AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc. in FY25. Company is planning to raise funds of fresh issue of Rs 353.4 Cr equity shares having the face value of Rs 2/ each, by issuing 12,792,056 equity shares through offer for sale.

Nephrocare Health Services Financial Highlights


For the full year FY2025–2026, revenue reached ₹769.92 crore and profit touched at ₹67.1 crore. As of Dec '25, Nephrocare Health Services’s market capitalisation stood at ₹5,839.33 crores. Shareholding as of Dec '25 shows promoters holding 63.8%, with FIIs at 9.3%, DIIs at 8.1%, and public at 18.7%.

Nephrocare Health Services Share Price Today


As of 12 Feb 2026, Nephrocare Health Services share price is ₹575.2. The stock opened at ₹582 and had closed at ₹582 the previous day. During today’s trading session, Nephrocare Health Services share price moved between ₹568.10 and ₹589.00, with an average price for the day of ₹578.55. Over the last 52 weeks, the stock has recorded a low of ₹446.00 and a high of ₹603.80. In terms of performance, Nephrocare Health Services share price has increased by 25% over the past six months and has increased by 13.67% over the last year.
Read More
View details of Market Depth

Nephrocare Health Services Fundamental

Market Cap (in crs)

5,839.33

Face Value

2

Turnover (in lacs)

1,054.04

Key Metrics

Qtr Change %
25
Dividend yield 1yr %
0

Nephrocare Health Services Key Financials

View more
Loading chart...
Nephrocare Health Services Quarterly Revenue
Nephrocare Health Services Yearly Revenue
Nephrocare Health Services Quarterly Net Profit/Loss
Nephrocare Health Services Yearly Net Profit/Loss

Nephrocare Health Services Result Highlights

  • Nephrocare Health Services Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.

  • Its expenses for the quarter were - by - QoQ and - - YoY.

  • The net profit - - QoQ and - - YoY.

  • The earnings per share (EPS) of Nephrocare Health Services Ltd stood at 3.35 during Q3 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Nephrocare Health Services Shareholding Pattern

Promoter
63.8%
Foreign Institutions
9.3%
Mutual Funds
3.1%
Domestic Institutions
8.1%
Public
18.7%

Nephrocare Health Services Technical Analysis

Moving Averages Analysis
575.25
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
0
Day EMA5
546.30
Day EMA10
533.70
Day EMA12
530.40
Day EMA20
519.40
Day EMA26
512.30
EMA
EMA
EMA
Delivery & Volume
Loading chart...

Day

17.00%

Week

19.40%

Month

34.40%

Delivery & Volume

576.65
Pivot
Resistance
First Resistance
609.10
Second Resistance
636.25
Third Resistance
668.70
Support
First Support
549.50
Second support
517.05
Third Support
489.90
Relative Strength Index
74.60
Money Flow Index
96.75
MACD
18.23
MACD Signal
15.39
Average True Range
23.75
Average Directional Index
32.25
Rate of Change (21)
19.84
Rate of Change (125)
0.00
Compare

Nephrocare Health Services Latest News

12 FEB 2026 | Thursday
12 FEB 2026 | Thursday
10 FEB 2026 | Tuesday

Please be aware that Nephrocare Health Services stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account